Background: In the management of lung cancer, molecular profiling of the tumor is pivotal to defining a personalized treatment plan and is recommended for each patient.
Background: Elucidation of key biomarkers, as indicators and drivers of the pathologic processes in cutaneous melanoma (CM), has led to the development of effective targeted therapies.
Of several barriers that hamper use of available healthcare services, Syrian refugees report that the financial barrier remains the major obstacle to...
Background: Excessive activation of the PI3K pathway has been associated with malignant transformation and resistance to treatment in various cancer...
